Boyd Biomedical’s Post

🔬 AI is reshaping the biotechnology landscape, accelerating up to 30% of breakthroughs and transforming how we develop life-saving solutions. 🌐 From optimizing manufacturing processes to streamlining research, AI's potential is enormous—but how well is it being harnessed in biotech today? 📊 Our latest post breaks down the trends from a recent study in the International Journal of Chemistry, Mathematics, and Physics, highlighting how innovation can push biotech companies toward real, impactful change. 📖 Curious to explore the full article or discuss how to amplify the science behind your innovations with design and communication? 🤝 Reach out to us—let's make science heard #biotech #Startups #Amplifytheimpact #Communication

🚀 Join Us for: Frontier Tech & AI Shaping the Future of Biotech! 🚀 🗓 Date: Aug 30  | ⏰ Time: 4:00 - 5:00 PM  |🌐 Virtual Session 🔍 What You’ll Learn: - How frontier tech & AI are transforming biotech - Innovations in drug discovery & personalized medicine - Advances in biomanufacturing - Challenges & ethical considerations 🔗 Register Now: https://lnkd.in/gHARtmZf Don’t miss out on this game-changing discussion! 💡✨ #AI #Biotech #Entrepreneurship

🔬 AI is reshaping the biotechnology landscape, driving up to 30% of breakthroughs and revolutionizing how life-saving solutions are developed. 🌐 The potential is immense, from optimizing manufacturing processes to accelerating research, but how well are biotech companies communicating these advancements? At We are Palta, we help deep tech companies clearly communicate the value of their solutions to reach broader audiences and maximize their impact. Strategic communication isn't just important, it's vital for innovation to truly change the world. Today, we're highlighting three inspiring examples of AI-powered biotech innovation: 🌾 DeepAgro: Leveraging AI to optimize precision agriculture. 🧫 Elytron: Applying AI to enhance agricultural productivity through microorganisms. 💊 Boolzi: Using AI to accelerate pharmaceutical innovation and optimize clinical trial design. These companies embody how AI is not just a tool but a catalyst for tangible, transformative change in different industries. 🚀 A recent study in the International Journal of Chemistry, Mathematics, and Physics emphasized how innovation can push biotech toward meaningful breakthroughs. But innovation alone isn’t enough—clear, compelling communication ensures these advances are understood, adopted, and amplified. 📖 Interested in diving into the study or discussing how we can amplify your science with design and communication? Let's collaborate and make sure your innovations reach the world! 🌟 #DeepTech #Biotech #Startups #AmplifyTheImpact #AI #Communication #Design

Can AI give your product a competitive advantage? 🤖 🤔 According to Lucas Nivon, CEO of Cyrus Biotechnology, it’s all about the innovation mindset. He warns against getting stuck on AI-driven tools just for the sake of them. “It’s less about #AI and more about making valuable products in the real world.” When Lucas spoke to Scott’s AI in #ProductDevelopment class this past spring at the University of Washington Bothell, he touched on AI's unique capabilities in #biotech and how those capabilities needed to be mapped to real clinical needs. “If you’re going to work in biologics, your new product has to be at the intersection of the two.” Although #genAI is transformative, its power is magnified tenfold or more when coupled with traditional AI and physics-based tools. Over time, AI tools will likely surpass traditional tools (it’s already beginning to happen), but in biologics discovery, it’s more about the clinical impact than the diversity of your models or ability to generate data. Lucas, thank you for letting us peek behind the Cyrus Biotech curtains and for teaching our future engineers about the importance of both a skill set and a mindset when it comes to AI-driven innovation.

Dive into the transformative world of Deep Tech innovation with Srikanth Velamakanni, Vice Chairperson of nasscom & Group CEO of Fractal, as he moderates a panel discussion on ‘The Intersection of DeepTech and Human Progress’, joined by industry leaders Deepak Anil Lala, Manager, Computational Medicine Lab, Cellworks, Aditi Vaidya, Co-founder, Quanfluence and Maruthi Amardeep Sri Vatsavaya, Co-founder & CEO, BluJ Aerospace Private Limited "Releasing the three-dimensional structure of 200 million proteins in 2022 was a game-changer, enabling us to unlock the key to developing vaccines and drugs with precision," highlights Srikanth Velamakanni, shedding light on how 3-D structure redefines scientific advancements. Catch the complete session to explore groundbreaking insights on computational medicine, AI-driven solutions, and aerospace innovation, and how these technologies are leading the charge towards a brighter future.   Watch the entire video here: https://lnkd.in/gVr4RcaD nasscom startups | Sangeeta Gupta | Kritika M | Sandeep Bahl | Shalini Dewan | Shreya Sharma | Nehal Pandya | Mayank Kumar | Shivam Sareen | Ashish Gupta | Aishwarya K | Ankita Puranik | Arihant Kothari | Khushbu Gupta | Meghna Girish | Prashant verma | Richpal Choudhary | Shivaling Salakki | Vinay Kumar C. | Jeyandran Venugopal | Abhinav Aggarwal | Ajeya Motaganahalli | Anish Agarwal | Anu Acharya | Arun Seth | Ashok Chandavarkar | Atul Batra | Naganand Doraswamy | Narendra Bhandari | Padmaja Ruparel | Palash Gupta #nasscomfutureforge2024 #nasscomdeeptech #nasscomstartups #deeptech

OpenAI has partnered with Retro Biosciences, a startup focused on longevity, to develop GPT-4b micro. This collaboration aims to leverage AI in the quest for extending human lifespan by a decade. According to MIT Technology Review, this partnership is backed by Sam Altman and involves over a year of research efforts. The primary goal is not just about increasing years lived but enhancing overall health and vitality as we age. Recent advancements in AI can dramatically enhance life sciences by processing vast datasets quickly, improving our understanding of aging mechanisms, and potentially leading to pioneering interventions. What does this mean for businesses in biotech and healthcare? Integrating advanced AI models like GPT-4b micro can speed up research timelines significantly. For startups and established companies alike: investing in AI-driven solutions could be crucial for developing innovative health products aimed at longevity. As the conversation around healthy aging grows more relevant each day, professionals should consider how their sectors may evolve with these technologies. I invite you all to share your thoughts on this intersection of AI and healthcare—what opportunities do you foresee from developments like these? 🤖🌱 Check out 🔔 gigabai.com 🔔 to automate your workflow today.

Recently had a chat with a physician and learned about how evolution mirrors technological innovation. There are two types of evolution: Drift and Shift. Drifting evolution is all about incremental improvements, taking what was and making the next version better. Shifting evolution is about step-leaps towards something altogether different. When a shift occurs, organisms that were drifting often can no longer compete as the velocity of their drift is not fast enough to catch up to the shift (e.g., when the flu virus shifts, the vaccine loses efficacy). There are great parallels to evaluating start-up ideas and thinking about innovation. Shifts like Mobile were pivotal in shaping our technology landscape today. Electrification is another shift well underway. Many believe AI represents another such shift. In my opinion the key takeaway comparing evolution and innovation is: If you can, it's nearly always better to work on something that's part of a shift. When you're drifting, you're almost certainly competing directly against an incumbent... and incumbents have become very good at value capture in the tech sector over the past few decades (probably a subject of a future post!). Doris McCarthy's Floes Floating, 2000

I was today years old when I learned that around 45% of patients in the U.S. are forced to visit the ER first instead of scheduling a doctor’s appointment. Intel Liftoff member Aleph Innovations is taking aim at critical bottlenecks in healthcare, and using AI to improve outcomes. Their exciting solutions prove that technology can drive systemic change, over and above the efficiency and cost saving improvements that AI is known for. Aleph Innovation is one of our most ambitious startups - and they’re at the beginning of their journey. They’re focusing on enabling more precise healthcare now, but they’re also looking ahead to other big picture goals like decarbonization. Read all about it, here: https://lnkd.in/dEPFgNfm #AIforGood #IntelLiftoff #HealthcareInnovation

The Future of Biotech: AI & Smart Funding Looking at the biotech landscape of 2024, it's clear that there are learnings from past 'glory days'. But what remains unchanged is the pursuit of that transformative molecule with great therapeutic promise. The biotech playground has morphed dramatically, demanding more astute and strategic funding approaches. And yet, amid this tougher environment, two catalysts emerge: AI and stable funding environments. Tracking back to a recent Financial Times Live event, experts highlighted the change occurring. AI is no longer a futuristic buzzword; it's a practical tool ramping up in drug discovery. With big pharma's significant cash reserves eyeing de-risked late-stage assets, a potential 'tension' brews between them and private equity's investment strategies. It's a fascinating balancing act between innovation and commercial foresight. #Biotech #AIInnovation #FundingStrategies 🌐

#AI-powered HealthTech #startups are not only improving patient care but also opening up lucrative opportunities for investors. By streamlining clinical operations and enabling faster, more accurate diagnoses, this sector is poised to revolutionize healthcare. AI is driving advancements in diagnostics, personalized treatment, and workflow automation. In my opinion, the most promising area of AI in HealthTech is drug discovery and development. By analyzing vast amounts of biological data, AI can accelerate the identification of potential drug targets and design novel molecules. This could lead to the development of new treatments for diseases that currently have limited options. 👉 What do you think? Which area of AI in HealthTech do you believe holds the most potential for future breakthroughs?